BNR — Burning Rock Biotech Share News
0.000.00%
Last trade - 00:00
- $73.93m
- -$11.03m
- CNY537.44m
- 63
- 55
- 27
- 46
REG - Burning Rock Biotech - BNR Announces Receipt of Notification from NASDAQ
AnnouncementREG - Burning Rock Biotech - BNR Announces Results of 2023 AGM
AnnouncementREG - Burning Rock Biotech - BNR Reports Third Quarter 2023 Financial Results
AnnouncementREG - Burning Rock Biotech - BNR Announces 2023 AGM to be Held on Dec 20, 2023
AnnouncementREG - Burning Rock Biotech - BNR Schedules Q3 Earnings Release on Nov 30, 2023
AnnouncementREG - Burning Rock Biotech - BNR and BI Achieved a Master Service Agreement
AnnouncementREG - Burning Rock Biotech - BNR Received Breakthrough Device Designation
AnnouncementREG - Burning Rock Biotech - Study results published in the Cancer Cell
AnnouncementREG - Burning Rock Biotech - BNR Reports Second Quarter 2023 Financial Results
AnnouncementREG - Burning Rock Biotech - BNR Schedules Earnings Release on August 31, 2023
AnnouncementREG - Burning Rock Biotech - Announces Resignation and Appointment of Directors
AnnouncementREG - Burning Rock Biotech - Published in the New England Journal of Medicine
AnnouncementREG - Burning Rock Biotech - Burning Rock Reports 1st Quarter Financial Results
AnnouncementREG - Burning Rock Biotech - BNR Schedules Q1 Earnings Release on May 30, 2023
AnnouncementREG - Burning Rock Biotech - BNR Publishes 2022 Annual Report on Form 20-F
AnnouncementREG - Burning Rock Biotech - Burning Rock Reports Q4 and Full Year 2022 Results
AnnouncementREG - Burning Rock Biotech - BNR Schedules 22Q4 and Full Year ER on March 28
AnnouncementREG - Burning Rock Biotech - An update on 2022 revenue guidance
AnnouncementREG - Burning Rock Biotech - BNR Received FDA Breakthrough Device Designation
Announcement